Presented During:
08/05/2021: 12:35 PM - 1:00 PM
Virtual
Conference:
2021: 71st ACA Annual Meeting
Session Type:
Oral Talk
Presenting Author :
Abstract Body:
Small molecule degraders have shown considerable promise as a new pharmacological modality. With the mounting structural information on degrader mediated ligase-substrate interactions we are beginning to understand the rationale for target recruitment and selectivity. This presentation will describe a structural basis for accelerating degrader design.
Which session are you submitting your abstract to?
3.2.3 Evolution and Impact of Targeted Protein Degradation in Industry
3.2.3 Evolution and Impact of Targeted Protein Degradation in Industry